Related Experiment Video
Updated: May 26, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy
Bryan R Conway1, Jillian Rennie, Matthew A Bailey
1MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, Scotland, UK. bryan.conway@ed.ac.uk
Abstract:
Rodent models exhibit only the earliest features of human diabetic nephropathy, which limits our ability to investigate new therapies. Hypertension is a prerequisite for advanced diabetic nephropathy in humans, so its rarity in typical rodent models may partly explain their resistance to nephropathy. Here, we used the Cyp1a1mRen2 rat, in which the murine renin-2 gene is incorporated under the Cytochrome P4501a1 promoter. In this transgenic strain, administration of low-dose dietary indole-3-carbinol induces moderate hypertension. In the absence of hypertension, streptozotocin-induced diabetes resulted in a 14-fold increase in albuminuria but only mild changes in histology and gene expression despite 28 weeks of marked hyperglycemia. In the presence of induced hypertension, hyperglycemia resulted in a 500-fold increase in albuminuria, marked glomerulosclerosis and tubulointerstitial fibrosis, and induction of many of the same pathways that are upregulated in the tubulointerstitium in human diabetic nephropathy. In conclusion, although induction of diabetes alone in rodents has limited utility to model human diabetic nephropathy, renin-dependent hypertension and hyperglycemia synergize to recapitulate many of the clinical, histological, and gene expression changes observed in humans.
Insights
Rodent models poorly mimic human diabetic nephropathy. Combining induced hypertension with diabetes in rats successfully recapitulated key human disease features, offering a better model for studying diabetic kidney disease therapies.
Area of Science:
- Nephrology
- Endocrinology
- Translational Medicine
Background:
- Rodent models of diabetic nephropathy (DN) display limited human disease features, hindering therapeutic development.
- Hypertension is crucial for advanced human DN but rare in standard rodent models, contributing to their resistance.
- The Cyp1a1mRen2 rat, a transgenic model, allows for induced hypertension via dietary indole-3-carbinol.
Purpose of the Study:
- To develop a more accurate rodent model for human diabetic nephropathy.
- To investigate the synergistic effects of hyperglycemia and renin-dependent hypertension on kidney damage.
- To evaluate the utility of the Cyp1a1mRen2 rat for modeling human DN.
Main Methods:
- Induction of diabetes using streptozotocin in Cyp1a1mRen2 rats.
- Induction of moderate hypertension using dietary indole-3-carbinol.
- Assessment of albuminuria, renal histology, and gene expression in diabetic rats with and without induced hypertension.
Main Results:
- Diabetes alone in rats caused mild kidney changes despite hyperglycemia and increased albuminuria.
- Concomitant diabetes and induced hypertension led to a significant increase in albuminuria (500-fold).
- Hypertension and hyperglycemia synergistically induced glomerulosclerosis, tubulointerstitial fibrosis, and gene expression patterns mirroring human DN.
Conclusions:
- Rodent models of diabetes alone are insufficient for modeling advanced human diabetic nephropathy.
- The combination of renin-dependent hypertension and hyperglycemia in the Cyp1a1mRen2 rat effectively recapitulates key aspects of human DN.
- This enhanced rodent model provides a valuable platform for investigating novel therapeutic strategies for diabetic kidney disease.
Related Concept Videos
Diabetic Nephropathy
Hypertension II: Pathophysiology
Type II Diabetes II: Pathophysiology
Antihypertensive Drugs: Direct Renin Inhibitors
Diabetic Retinopathy
Diabetes Insipidus II: Pathophysiology
